{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:27:13Z","timestamp":1741667233699,"version":"3.38.0"},"posted":{"date-parts":[[2024,7,23]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,19]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>INTRODUCTION:<\/bold> We investigated how cerebrospinal fluid levels of synaptic proteins associate with memory function in normal cognition (CN) and mild cognitive impairment (MCI), and investigated the effect of amyloid positivity on these associations.\n<bold>METHODS:<\/bold> We included 242 CN (105(43%) abnormal amyloid), and 278 MCI individuals (183(66%) abnormal amyloid) from EMIF-AD MBD and ADNI. For 181 (EMIF-AD MBD) and 36 (ADNI) proteins with a synaptic annotation in SynGO, associations with word learning recall were analysed with linear models.\n<bold>RESULTS:<\/bold> Subsets of synaptic proteins showed lower levels with worse recall in preclinical AD (EMIF-AD MBD: 7, ADNI: 5 proteins, none overlapping), prodromal AD (EMIF-AD MBD only, 27 proteins) and non-AD MCI (EMIF-AD MBD: 1, ADNI: 7 proteins). The majority of these associations were specific to these groups.\n<bold>DISCUSSION: <\/bold>Synaptic disturbance-related memory impairment occurred very early in AD, indicating it may be relevant to develop therapies targeting the synapse early in the disease.<\/p>","DOI":"10.21203\/rs.3.rs-4607202\/v1","type":"posted-content","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T13:25:49Z","timestamp":1721741149000},"source":"Crossref","is-referenced-by-count":0,"title":["Synaptic protein CSF levels relate to memory scores in individuals without dementia"],"prefix":"10.21203","author":[{"given":"Kirsten E.J.","family":"Wesenhagen","sequence":"first","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederick M.","family":"de Leeuw","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jori","family":"Tomassen","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Gobom","sequence":"additional","affiliation":[{"name":"Sahlgrenska University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bos","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.B.","family":"Vos","sequence":"additional","affiliation":[{"name":"Alzheimer Center Limburg, Maastricht University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Martinez-Lage","sequence":"additional","affiliation":[{"name":"CITA-Alzheimer Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikel","family":"Tainta","sequence":"additional","affiliation":[{"name":"CITA-Alzheimer Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Popp","sequence":"additional","affiliation":[{"name":"University Hospital of Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendoline","family":"Peyratout","sequence":"additional","affiliation":[{"name":"University Hospital of Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[{"name":"AHEPA University Hospital, Aristotle University of Thessaloniki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Freund-Levi","sequence":"additional","affiliation":[{"name":"Karolinska Institutet"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Verhey","sequence":"additional","affiliation":[{"name":"Alzheimer Center Limburg, Maastricht University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[{"name":"University of Oxford"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Streffer","sequence":"additional","affiliation":[{"name":"University of Antwerp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerija","family":"Dobricic","sequence":"additional","affiliation":[{"name":"University of L\u00fcbeck"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August B.","family":"Smit","sequence":"additional","affiliation":[{"name":"VU University Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bertram","sequence":"additional","affiliation":[{"name":"University of L\u00fcbeck"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Sahlgrenska University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty M.","family":"Tijms","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[{"name":"Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"the Alzheimer\u2019s Disease Neuroimaging","family":"Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"ADNI General Procedures Manual [WWW Document]. 2006. URL http:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2010\/09\/ADNI_GeneralProceduresManual.pdf (accessed 8.13.20)."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","article-title":"Synaptic degeneration in Alzheimer\u2019s disease","volume":"118","author":"Arendt T","year":"2009","unstructured":"Arendt T. Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118:167\u201379. https:\/\/doi.org\/10.1007\/s00401-009-0536-x.","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1021\/pr500893m","article-title":"Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics","volume":"13","author":"Batth TS","year":"2014","unstructured":"Batth TS, Francavilla C, Olsen JV. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res. 2014;13:6176\u201386. https:\/\/doi.org\/10.1021\/pr500893m.","journal-title":"J Proteome Res"},{"issue":"1 3","key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-017-0008-2","article-title":"Synaptic proteins in CSF relate to Parkinson\u2019s disease stage markers","volume":"2017 3","author":"Bereczki E","year":"2017","unstructured":"Bereczki E, Bogstedt A, H\u00f6glund K, Tsitsi P, Brodin L, Ballard C, Svenningsson P, Aarsland D. Synaptic proteins in CSF relate to Parkinson\u2019s disease stage markers. npj Parkinson\u2019s Disease. 2017;2017 3(1 3):1\u20135. https:\/\/doi.org\/10.1038\/S41531-017-0008-2.","journal-title":"npj Parkinson\u2019s Disease"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jalz.2014.04.520","article-title":"Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample","volume":"10","author":"Bilgel M","year":"2014","unstructured":"Bilgel M, An Y, Lang A, Prince J, Ferrucci L, Jedynak B, Resnick SM. Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample. Alzheimer\u2019s Dement. 2014;10:735\u2013e7424. https:\/\/doi.org\/10.1016\/j.jalz.2014.04.520.","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-018-0396-5","article-title":"2018. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics","volume":"10","author":"Bos I","unstructured":"Bos I, Vos S, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni G, Molinuevo JL, Wallin A, Lle\u00f3 A, Popp J, Martinez-Lage P, Baird A, Dobson R, Legido-Quigley C, Sleegers K, Van Broeckhoven C, Bertram L, ten Kate M, Barkhof F, Zetterberg H, Lovestone S, Streffer J, Visser PJ. 2018. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. Alzheimers Res Ther 10, 64. https:\/\/doi.org\/10.1186\/s13195-018-0396-5.","journal-title":"Alzheimers Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/WNL.0000000000004569","article-title":"Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers","volume":"89","author":"Casaletto KB","year":"2017","unstructured":"Casaletto KB, Elahi FM, Bettcher BM, Neuhaus J, Bendlin BB, Asthana S, Johnson SC, Yaffe K, Carlsson C, Blennow K, Zetterberg H, Kramer JH. Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers. Neurology. 2017;89:1782\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000004569.","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1017\/S1355617719001103","article-title":"The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias","volume":"26","author":"Ciafone J","year":"2020","unstructured":"Ciafone J, Little B, Thomas AJ, Gallagher P. The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias. J Int Neuropsychol Soc. 2020;26:210\u201325. https:\/\/doi.org\/10.1017\/S1355617719001103.","journal-title":"J Int Neuropsychol Soc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Colom-Cadena M","year":"2020","unstructured":"Colom-Cadena M, Spires-Jones T, Zetterberg H, et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alz Res Therapy. 2020;12:21. https:\/\/doi.org\/10.1186\/s13195-020-00588-4.","journal-title":"Alz Res Therapy"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.3390\/ijms21218335","article-title":"Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"21","author":"Dulewicz M","year":"2020","unstructured":"Dulewicz M, Kulczy\u0144ska-Przybik A, Mroczko B. Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2020;21:8335. https:\/\/doi.org\/10.3390\/ijms21218335.","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/FNCEL.2021.626128","article-title":"Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson\u2019s Disease","author":"Gcwensa NZ","year":"2021","unstructured":"Gcwensa NZ, Russell DL, Cowell RM, Volpicelli-Daley LA. Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson\u2019s Disease. Front Cell Neurosci. 2021;0:44. https:\/\/doi.org\/10.3389\/FNCEL.2021.626128.","journal-title":"Front Cell Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e887","DOI":"10.1212\/WNL.0000000000005057","article-title":"Neurogranin as a predictor of memory and executive function decline in MCI patients","volume":"90","author":"Headley A","year":"2018","unstructured":"Headley A, De Leon-Benedetti A, Dong C, Levin B, Loewenstein D, Camargo C, Rundek T, Zetterberg H, Blennow K, Wright CB, Sun X. Neurogranin as a predictor of memory and executive function decline in MCI patients. Neurology. 2018;90:e887\u201395. https:\/\/doi.org\/10.1212\/WNL.0000000000005057.","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.04.040","article-title":"n.d. Extracellular Forms of Ab and Tau from iPSC Models of Alzheimer\u2019s Disease Disrupt","author":"Hu N-W","unstructured":"Hu N-W, Corbett GT, Moore S, Walsh DM, Livesey FJ, Rowan MJ. n.d. Extracellular Forms of Ab and Tau from iPSC Models of Alzheimer\u2019s Disease Disrupt Synaptic Plasticity Correspondence. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.040."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/J.JALZ.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack CR","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Elliott C, Masliah E, Ryan L, Silverberg N. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/J.JALZ.2018.02.018.","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4668","author":"Jansen WJ","year":"1924","unstructured":"Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, F\u00f6rster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, G\u00f3mez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka S-K, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, K\u00f6hler S, Koglin N, Kornhuber J, Kramberger MG, van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lle\u00f3 A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendon\u00e7a A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, M\u00f8llerg\u00e5rd HM, Morris JC, Mroczko B, van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IHGB, Rami L, de Oliveira R, Rinne C, Rodrigue JO, Rodr\u00edguez-Rodr\u00edguez KM, Roe E, Rot CM, Rowe U, R\u00fcther CC, Sabri E, Sanchez-Juan O, Santana P, Sarazin I, Schr\u00f6der M, Sch\u00fctte J, Seo C, Soetewey SW, Soininen F, Spiru H, Struyfs L, Teunissen H, Tsolaki CE, Vandenberghe M, Verbeek R, Villemagne MM, Vos VL, S.J.B., van Waalwijk G, Wallin. A., Wallin, \u00c5.K., Wiltfang, J., Wolk, D.A., Zboch, M., Zetterberg, H., Zetterberg, H., 2015. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia. JAMA 313, 1924. https:\/\/doi.org\/10.1001\/jama.2015.4668."},{"author":"Jansen WJ","key":"ref16","doi-asserted-by":"publisher","unstructured":"Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lle\u00f3 A, Mintun MA, Wallin A, Engelborghs S, Na DL, Ch\u00e9telat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendon\u00e7a A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, F\u00f6rster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka S-K, Johannsen P, Klimkowicz-Mrowiec A, K\u00f6hler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, M\u00f8llerg\u00e5rd HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodr\u00edguez-Rodr\u00edguez E, Roe CM, Rot U, R\u00fcther E, Santana I, Schr\u00f6der J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos, S.J.B., van Waalwijk, van Doorn, L.J.C., Waldemar. G., Wallin, \u00c5.K., Wiltfang, J., Zetterberg, H., 2018. Association of Cerebral Amyloid-\u03b2 Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75, 84. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3391.","DOI":"10.1001\/jamapsychiatry.2017.3391"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S1355617720000934","article-title":"Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer\u2019s Disease","volume":"27","author":"Jutten RJ","year":"2021","unstructured":"Jutten RJ, Sikkes SAM, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Teunissen CE, van Berckel BNM, van der Flier WM, Scheltens P, Sperling RA, Papp Kv. Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer\u2019s Disease. J Int Neuropsychol Soc. 2021;27:426\u201338. https:\/\/doi.org\/10.1017\/S1355617720000934.","journal-title":"J Int Neuropsychol Soc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/J.JALZ.2017.04.002","article-title":"Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability","volume":"13","author":"Kaniyappan S","year":"2017","unstructured":"Kaniyappan S, Chandupatla RR, Mandelkow E-M, Mandelkow E. Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability. Alzheimer\u2019s Dement. 2017;13:1270\u201391. https:\/\/doi.org\/10.1016\/J.JALZ.2017.04.002.","journal-title":"Alzheimer\u2019s Dement"},{"year":"2019","author":"Koopmans F","key":"ref19","unstructured":"Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, Cornelisse LN, Farrell RJ, Goldschmidt HL, Howrigan DP, Hussain NK, Imig C, de Jong APH, Jung H, Kohansalnodehi M, Kramarz B, Lipstein N, Lovering RC, MacGillavry H, Mariano V, Mi H, Ninov M, Osumi-Sutherland D, Pielot R, Smalla KH, Tang H, Tashman K, Toonen RFG, Verpelli C, Reig-Viader R, Watanabe K, van Weering J, Achsel T, Ashrafi G, Asi N, Brown TC, De Camilli P, Feuermann M, Foulger RE, Gaudet P, Joglekar A, Kanellopoulos A, Malenka R, Nicoll RA, Pulido C, de Juan-Sanz J, Sheng M, S\u00fcdhof TC, Tilgner HU, Bagni C, Bay\u00e9s \u00c0, Biederer T, Brose N, Chua JJE, Dieterich DC, Gundelfinger ED, Hoogenraad C, Huganir RL, Jahn R, Kaeser PS, Kim E, Kreutz MR, McPherson PS, Neale BM, O\u2019Connor V, Posthuma D, Ryan TA, Sala C, Feng G, Hyman SE, Thomas PD, Smit AB, Verhage M. 2019. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron 103, 217\u2013234.e4. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.002."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease","volume":"11","author":"Kvartsberg H","year":"2015","unstructured":"Kvartsberg H, Duits FH, Ingelsson M, Andreasen N, \u00d6hrfelt A, Andersson K, Brinkmalm G, Lannfelt L, Minthon L, Hansson O, Andreasson U, Teunissen CE, Scheltens P, van der Flier WM, Zetterberg H, Portelius E, Blennow K. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2015;11:1180\u201390. https:\/\/doi.org\/10.1016\/j.jalz.2014.10.009.","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12353","article-title":"Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease","author":"Libiger O","year":"2021","unstructured":"Libiger O, Shaw LM, Watson MH, Nairn AC, Uma\u00f1a KL, Biarnes MC, Canet-Avil\u00e9s RM, Jack CR, Breton YA, Cortes L, Chelsky D, Spellman DS, Baker SA, Raghavan N, Potter WZ. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2021. https:\/\/doi.org\/10.1002\/alz.12353.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1 10","key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41398-020-0801-2","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment","volume":"10","author":"Liu W","year":"2020","unstructured":"Liu W, Lin H, He X, Chen, Lewen, Dai Y, Jia W, Xue X, Tao J, Chen L. Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment. Translational Psychiatry 2020. 2020;10(1 10):1\u20139. https:\/\/doi.org\/10.1038\/S41398-020-0801-2.","journal-title":"Translational Psychiatry 2020"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid. Molecular & Cellular Proteomics mcp.RA118.001290","author":"Lle\u00f3 A","year":"2019","unstructured":"Lle\u00f3 A, N\u00fa\u00f1ez-Llaves R, Alcolea D, Chiva C, Balateu-Pa\u00f1os D, Colom-Cadena M, Gomez-Giro G, Mu\u00f1oz L, Querol-Vilaseca M, Pegueroles J, Rami L, Llad\u00f3 A, Molinuevo J, Tainta M, Clarim\u00f3n J, Spires-Jones T, Blesa R, Fortea J, Mart\u00ednez-Lage P, S\u00e1nchez-Valle R, Sabid\u00f3 E, Bay\u00e9s \u00c0, Belbin O. 2019. Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid. Molecular & Cellular Proteomics mcp.RA118.001290. https:\/\/doi.org\/10.1074\/mcp.RA118.001290."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2017.01.016","article-title":"Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics","volume":"37","author":"Magdalinou NK","year":"2017","unstructured":"Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holm\u00e9n-Larsson J, Holtta M, Blennow K, Morris HR, Skillb\u00e4ck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. Parkinsonism Relat Disord. 2017;37:65\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.01.016.","journal-title":"Parkinsonism Relat Disord"},{"issue":"126","key":"ref25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/S00702-019-02003-1","article-title":"Mild cognitive impairment in Parkinson\u2019s disease","volume":"126","author":"Martinez-Horta S","year":"2019","unstructured":"Martinez-Horta S, Kulisevsky J. Mild cognitive impairment in Parkinson\u2019s disease. J Neural Transmission 2019. 2019;126(126):7. https:\/\/doi.org\/10.1007\/S00702-019-02003-1.","journal-title":"J Neural Transmission 2019"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/wnl.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease","volume":"56","author":"Masliah E","year":"2001","unstructured":"Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, Morris JC. Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease. Neurology. 2001;56:127\u20139. https:\/\/doi.org\/10.1212\/wnl.56.1.127.","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-3940(94)90121-X","article-title":"Synaptic and neuritic alterations during the progression of Alzheimer\u2019s disease","volume":"174","author":"Masliah E","year":"1994","unstructured":"Masliah E, Mallory M, Hansen L, Richard DT, Alford M, Terry R. Synaptic and neuritic alterations during the progression of Alzheimer\u2019s disease. Neurosci Lett. 1994;174:67\u201372. https:\/\/doi.org\/10.1016\/0304-3940(94)90121-X.","journal-title":"Neurosci Lett"},{"author":"Assays MRM","key":"ref28","unstructured":"Assays MRM. Caprion [WWW Document], n.d. URL http:\/\/www.caprion.com\/en\/technology\/mrm-assays.php (accessed 8.27.19)."},{"author":"Myriad RBM","key":"ref29","unstructured":"Myriad RBM, Operational Procedures White Paper - Myriad RBM [WWW, Document]. n.d. URL https:\/\/myriadrbm.com\/scientific-media\/myriad-rbm-operational-procedures-white-paper\/ (accessed 8.27.19)."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12179","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease","volume":"13","author":"Nilsson J","year":"2021","unstructured":"Nilsson J, Gobom J, Sj\u00f6din S, Brinkmalm G, Ashton NJ, Svensson J, Johansson P, Portelius E, Zetterberg H, Blennow K, Brinkmalm A. Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2021;13. https:\/\/doi.org\/10.1002\/dad2.12179.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.022","article-title":"Soluble tau aggregates inhibit synaptic long-term depression and amyloid \u03b2-facilitated LTD in vivo","author":"Ondrejcak T","year":"2019","unstructured":"Ondrejcak T, Hu N-W, Qi Y, Klyubin I, Corbett GT, Fraser G, Perkinton MS, Walsh DM, Billinton A, Rowan MJ. 2019. Soluble tau aggregates inhibit synaptic long-term depression and amyloid \u03b2-facilitated LTD in vivo. https:\/\/doi.org\/10.1016\/j.nbd.2019.03.022."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease","author":"Pereira JB","year":"2020","unstructured":"Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R, Zetterberg H, Blennow K, Hansson O. 2020. Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awaa395."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen RC","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01388.x.","journal-title":"J Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/GLIA.23163","article-title":"Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons","volume":"65","author":"Piacentini R","year":"2017","unstructured":"Piacentini R, Puma DDL, Mainardi M, Lazzarino G, Tavazzi B, Arancio O, Grassi C. Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons. Glia. 2017;65:1302\u201316. https:\/\/doi.org\/10.1002\/GLIA.23163.","journal-title":"Glia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: Relation to cognition and neurodegeneration in Alzheimer\u2019s disease","volume":"138","author":"Portelius E","year":"2015","unstructured":"Portelius E, Zetterberg H, Skillb\u00e4ck T, T\u00f6rnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K. Cerebrospinal fluid neurogranin: Relation to cognition and neurodegeneration in Alzheimer\u2019s disease. Brain. 2015;138:3373\u201385. https:\/\/doi.org\/10.1093\/brain\/awv267.","journal-title":"Brain"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","article-title":"Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease","volume":"11","author":"Scheff SW","year":"1990","unstructured":"Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease. Neurobiol Aging. 1990;11:29\u201337. https:\/\/doi.org\/10.1016\/0197-4580(90)90059-9.","journal-title":"Neurobiol Aging"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/00005072-199812000-00006","article-title":"Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease","volume":"57","author":"Scheff SW","year":"1998","unstructured":"Scheff SW, Price DA. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J Neuropathol Exp Neurol. 1998;57:1146\u201353. https:\/\/doi.org\/10.1097\/00005072-199812000-00006.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment","volume":"27","author":"Scheff SW","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging. 2006;27:1372\u201384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012.","journal-title":"Neurobiol Aging"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/JAD-122353","article-title":"Synapse Stability in the Precuneus Early in the Progression of Alzheimer\u2019s Disease","volume":"35","author":"Scheff SW","year":"2013","unstructured":"Scheff SW, Price DA, Schmitt FA, Roberts KN, Ikonomovic MD, Mufson EJ. Synapse Stability in the Precuneus Early in the Progression of Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease. 2013;35:599\u2013609. https:\/\/doi.org\/10.3233\/JAD-122353.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3233\/JAD-2011-101782","article-title":"Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer\u2019s disease","volume":"24","author":"Scheff SW","year":"2011","unstructured":"Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2011;24:547\u201357. https:\/\/doi.org\/10.3233\/JAD-2011-101782.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e97514","DOI":"10.1371\/journal.pone.0097514","article-title":"Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity","volume":"9","author":"Sun N","year":"2014","unstructured":"Sun N, Chan F-Y, Lu Y-J, Neves MAC, Lui H-K, Wang Y, Chow K-Y, Chan K-F, Yan S-C, Leung Y-C, Abagyan R, Chan T-H, Wong K-Y. Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity. PLoS ONE. 2014;9:e97514. https:\/\/doi.org\/10.1371\/journal.pone.0097514.","journal-title":"PLoS ONE"},{"key":"ref42","unstructured":"SynGO - Synaptic. Gene Ontologies and annotations [WWW Document], n.d. URL https:\/\/www.syngoportal.org\/ (accessed 12.24.21)."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease","volume":"73","author":"Tarawneh R","year":"2016","unstructured":"Tarawneh R, D\u2019Angelo G, Crimmins D, Herries E, Griest T, Fagan AM, Zipfel GJ, Ladenson JH, Morris JC, Holtzman DM. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease. JAMA Neurol. 2016;73:561. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0086.","journal-title":"JAMA Neurol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa325","article-title":"Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics (in press)","author":"Tijms BM","year":"2020","unstructured":"Tijms BM. 2020. Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics (in press). Brain. https:\/\/doi.org\/10.1093\/brain\/awaa325."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1373\/clinchem.2017.281055","article-title":"Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-\u03b2 1\u201342 analysis results","volume":"64","author":"Tijms BM","year":"2018","unstructured":"Tijms BM, Willemse EAJ, Zwan MD, Mulder SD, Visser PJ, van Berckel BNM, van der Flier WM, Scheltens P, Teunissen CE. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-\u03b2 1\u201342 analysis results. Clin Chem. 2018;64:576\u201385. https:\/\/doi.org\/10.1373\/clinchem.2017.281055.","journal-title":"Clin Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.NEUROBIOLAGING.2019.02.020","article-title":"Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project","volume":"79","author":"Timmers T","year":"2019","unstructured":"Timmers T, Ossenkoppele R, Verfaillie SCJ, van der Weijden CWJ, Slot RER, Wesselman LMP, Windhorst AD, Wolters EE, Yaqub M, Prins ND, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BNM. Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project. Neurobiol Aging. 2019;79:50\u20138. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2019.02.020.","journal-title":"Neurobiol Aging"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","article-title":"2021. \u03b1-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss","volume":"41","author":"Trudler D","unstructured":"Trudler D, Sanz-Blasco S, Eisele YS, Ghatak S, Bodhinathan K, Akhtar MW, Lynch WP, Pi\u00f1a-Crespo JC, Talantova M, Kelly JW, Lipton SA. 2021. \u03b1-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss. J Neurosci 41, 2264\u201373. https:\/\/doi.org\/10.1523\/JNEUROSCI.1871-20.2020.","journal-title":"J Neurosci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras M","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, et al. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol. 2023;19:19\u201338. https:\/\/doi.org\/10.1038\/s41582-022-00749-z.","journal-title":"Nat Rev Neurol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","author":"Winblad B","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, B\u00e4ckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, De Leon M, Decarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, Van Duijn C, Visser P, Petersen RC. Mild cognitive impairment - Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med J Intern Med. 2004;240\u20136. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01380.x.","journal-title":"J Intern Med J Intern Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4607202\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4607202\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:48:07Z","timestamp":1741628887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4607202\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4607202\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13195-025-01703-z","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,7,23]]},"subtype":"preprint"}}